Applied Microbiology · 1970 · 28 citations · 8 references
Life SciencesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingResistance In Gram-positive BacteriaGentamicin TherapyPseudomonas Aeruginosa ResistancePseudomonas SpeciesResistance In Clinical Isolates
Seventy-eight of 420 clinical isolates of Pseudomonas aeruginosa yielded zones of inhibition of less than 12 mm in diameter around 10-mug discs of gentamicin sulfate when tested by the standardized Bauer-Kirby disc diffusion method. Of 153 strains chosen from these isolates, one strain (0.65%) required 25 mug of gentamicin per ml for inhibition; the remainder (99.35%) were inhibited by 6 mug/ml or less of the antibiotic. It is recommended that those isolates of P. aeruginosa that yield zones of inhibition less than 12 mm in diameter be disc susceptibility-tested once more; those isolates that give zones of inhibition of less than 12 mm upon repeated examination should then be subjected to the broth dilution test before they are designated as sensitive or resistant to gentamicin.
8
GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC COMPLEX.
Melvin Weinstein, George M. Luedemann, Edwin M. Oden et al. · PubMed · 1963 · 130 citations
Laboratory and Clinical Studies of Gentamicin
Roger J. Bulger · Annals of Internal Medicine · 1963 · 88 citations